Skip to product information
1 of 1

GeneBio Systems

Fluor® 488 Anti-Human CD38 Antibody[HIT2]

Fluor® 488 Anti-Human CD38 Antibody[HIT2]

SKU:GBS-F1058L

Regular price €313,95 EUR
Regular price Sale price €313,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size:100Tests

Storage:This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Flow Cytometry Antibodies

Abbreviation:CD38

Target Synonym:2'-phospho-ADP-ribosyl cyclase;2'-phospho-cyclic-ADP-ribose transferase;ADP-ribosyl cyclase 1;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1;ADPRC 1;CD38;Cyclic ADP-ribose hydrolase 1;T10;cADPr hydrolase 1

Research Areas:Immunology

Conjugation:Elab Fluor®488

Host:Mouse

Species reactivity:Human

Application:FCM

Usage:Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.

Isotype:Mouse IgG1, κ

Clonality:Monoclonal

Clone NO.:HIT2

UNIProt ID:P28907

Background:CD38 is a 45 kD type II transmembrane glycoprotein also known as T10. It is an ADP-ribosyl hydrolase expressed at variable levels on hematopoietic cells and in some non-hematopoietic tissues (such as brain, muscles, and kidney). In humans, it is expressed at high levels on plasma cells and activated T and B cells. By functioning as both a cyclase and a hydrolase, CD38 mediates lymphocyte activation, adhesion, and the metabolism of cADPR and NAADP. CD31 is the ligand of CD38.

Concentration:5 μL/Test

Control catalog number:E-AB-F09792L

Immunogen:

Buffer:Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.

Purification method:

Dilution:

GeneID:952

View full details